ORKA
Oruka Therapeutics, Inc.
84.50$
+1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 21 | Q1 22 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -100.0% | – | – | – | +0.0% | +18.8% | +5.3% | +40.0% | +53.6% | +0.0% | – | |
| – | – | – | +703.5% | – | – | – | +4.0% | +100.2% | -59.5% | +69.3% | +4.5% | – | |
| – | -310.1% | – | -101.2% | – | -45.8% | -176.2% | – | – | – | -54.5% | +0.4% | – | |
| – | -71.4% | -100.0% | – | – | -89.5% | -27.8% | +161.5% | +191.2% | -36.4% | +15.9% | -100.0% | – | |
| – | -71.4% | – | – | – | +192,856.7% | – | -88.7% | -2,619.5% | -82.0% | -34.4% | +2,746.5% | – | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | – | – | -99.9% | +3,214,550.0% | -100.1% | -100.0% | – | +155,778.9% | -99.8% | +13,524.2% | +1,533.1% | – | |
| – | – | – | -109.4% | – | -192.5% | – | -182.6% | – | -271.4% | – | +8,370.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.